Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Next-Generation Assay Platform Expands Cell Analysis for Life Science Researchers

Published: Monday, August 18, 2014
Last Updated: Monday, August 18, 2014
Bookmark and Share
The Countess II FL cell-counting instrument’s modular design broadens the number of applications possible.

Life science researchers who want to expand their capabilities beyond traditional cell counting instruments can now do so with the Countess II FL, a next-generation, bench-top assay instrument with a modular design that broadens the number of applications on a single platform.

While most cell counters on the market have been limited to green and red fluorescent protein (GFP/RFP) channels, the new Countess II FL Automated Cell Counter is a three-channel (brightfield and two optional fluorescence channels) system that uses state-of-the-art optics and image analysis to perform assays for cells in suspension, including cell counting, fluorescent protein expression, apoptosis, cell viability and cell cycle assays. Designed with flexibility in mind, the Countess II FL can also be configured to use a full range of EVOS light cubes that provide more than 13 fluorescence color options.

The instrument is competitively priced to fit the budget of most laboratories and can operate with a reusable glass chamber slide to reduce the cost of consumables. Disposable slides are also available for simplicity and easy clean-up. As research needs and lab budgets increase, the Countess II FL can be upgraded at any time from a brightfield counter (without light cubes) to a multi-application fluorescent system with the EVOS light cubes.

“I would describe the new Countess II FL as accurate, consistent and effortless,” said Ravi Pathak, Ph.D., post doctorate associate in the Sikora lab of Immunology at Baylor College of Medicine. “The most important upgrade is the system’s multiple channel fluorescence capabilities, which would benefit our lab by enabling us to analyze multiple cells at once. This new instrument could also allow us to do quick and preliminary analysis of cells preemptively to more expensive downstream analyses.”

The new instrument builds on the success of its predecessor, which was first introduced to the market in 2008. Like the first-generation instrument, the Countess II FL Automated Cell Counter uses trypan blue staining combined with a sophisticated image analysis algorithm to produce accurate cell and viability counts in seconds.

“Our goal is to provide our customers with innovative tools that are designed to grow with the needs of their research and to meet their budgetary demands,” said Brett Williams, vice president and general manager, Cell Analysis, at Thermo Fisher Scientific. “With the launch of the Countess II FL, we are introducing a platform that enables multiple applications in a single instrument that helps keep down cost and moves science forward.”

The Countess II FL Automated Cell Counter is for research use only, not intended for diagnostic purposes.



Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Agrees to Buy Alfa Aesar for $403M
The company announced a definitive agreement to buy the research chemical manufacturer for $403 million.
Friday, June 26, 2015
Thermo Fisher Q3 Revenues up 31 Percent
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.
Thursday, October 23, 2014
Thermo Reports 22% Revenue Rise in Q1 2014
Results include the addition of Life Technologies as of February 4, 2014, and exclude the previously announced related divestitures as of March 22, 2014.
Wednesday, April 23, 2014
Thermo Completes Sale of Certain Assets to GE
Thermo has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare for $1.065 billion.
Monday, March 24, 2014
Thermo Completes Life Tech Acquisition
The completion of the transaction follows the receipt of all required regulatory approvals.
Tuesday, February 04, 2014
Thermo Reports 6% Q4 Revenue Growth
Thermo Fisher Scientific Inc. reported its financial results for the fourth quarter and full year ended December 31, 2013.
Friday, January 31, 2014
Thermo Receives EC Clearance for Life Tech Acquisition
Thermo Fisher Scientific announced that it has received approval from the European Commission (EC) for its pending acquisition of Life Technologies Corporation.
Tuesday, November 26, 2013
Record Revenues for Thermo Fisher Scientific
Revenue for the quarter grew 6% to $3.26 billion in 2012, versus $3.09 billion in 2011.
Thursday, January 31, 2013
Scientific News
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Editing of Embryos Approved in the UK
The Human Fertilisation and Embryology Authority (HFEA) has approved a research application from the Francis Crick Institute to use new "gene editing" techniques on human embryos.
Microbes Take Their Vitamins
Scientists exploit organisms' needs in order to track 'vitamin mimics' in bacteria.
Machine Learning Uncovers Unknown Bacterial Features
Technique robustly identified characteristic gene expression patterns in response to antibiotics, low oxygen conditions.
CRISPR-Cas9 Gene Editing Advances Again
UC Berkeley researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.
Disrupting Cell’s Supply Chain Freezes Cancer Virus
When the cancer-causing Epstein-Barr virus moves into a B-cell of the human immune system, it tricks the cell into rapidly making more copies of itself, each of which will carry the virus.
Why Do Some Infections Persist?
In preparing for the possibility of an antibiotic onslaught, some bacterial cultures adopt an all-for-one/one-for-all strategy that would make a socialist proud, University of Vermont researchers have found.
ASCB: A CELLebration of Cell Biology
The last major congress of the year, ASCB is less a platform for launching new products, but one for confirming and consolidating the trends that have emerged over the past 12 months.
Squeezing Cells into Stem Cells
EPFL scientists have developed a new method that helps cells turn in usable stem cells. The new approach involves “squeezing” cells with a gel, and paves the way for large-scale production of stem cells for medical purposes.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!